Oregon Secretary of State

Oregon Medical Board

Chapter 847

Division 15
GENERAL LICENSING RULES, RELATING TO CONTROLLED SUBSTANCES

847-015-0050
Expedited Partner Therapy for Sexually Transmitted Infection

The Oregon Medical Board recognizes that the adequate treatment of sexually transmitted infections is a public health issue. When identified in a patient, the adequate treatment and prevention of recurrence in the patient often depends upon treatment of the partner or partners of a patient, who may not be available or agreeable for clinical evaluation.

(1) As used in this rule:

(a) “Expedited partner therapy” has the meaning given in ORS 676.350, the practice of prescribing or dispensing antibiotic drugs for the treatment of a sexually transmitted infection to the partner of a patient without first examining the partner of the patient.

(b) “Partner of a patient” has the meaning given in ORS 676.350, a person whom a patient diagnosed with a sexually transmitted infection identifies as a sexual partner of the patient.

(2) A physician or physician assistant treating sexually transmitted infections, may engage in open discussions with a patient to ascertain the ability for a partner of a patient to access medical services.

(3) A licensee, otherwise permitted by law to prescribe or dispense controlled substances, may practice expedited partner therapy for the treatment of sexually transmitted chlamydia and gonorrhea infections.

(4) A licensee may initiate expedited partner therapy when the licensee reasonably believes that a partner of a patient will be unwilling or unable to seek treatment within the context of a traditional provider-patient relationship.

(5) When initiating expedited partner therapy, a licensee must:

(a) Instruct the patient regarding expedited partner therapy and the medications involved.

(b) Ensure appropriate information and advice are made available to the partner of a patient, including educational materials for the patient to share with their partner(s) encouraging the partner to consult a health care provider and disclosing potential adverse drug reactions and dangerous interactions between medications.

(c) Make reasonable efforts to refer the partner of a patient to appropriate health care professionals.

(6) Except as provided in this rule, a licensee may not write prescriptions unless they have conducted an adequate encounter with the patient, and documented this encounter in the medical record.

(7) The partner of a patient is considered to be an individual entitled to receive the prescription drug, and nothing in this rule is intended to establish a professional relationship between the physician or physician assistant and the partner of a patient.

Statutory/Other Authority: ORS 677.265 & ORS 676.350
Statutes/Other Implemented: ORS 676.350
History:
OMB 15-2022, adopt filed 07/12/2022, effective 07/12/2022


Please use this link to bookmark or link to this rule.